It is often stated that individuals of a species can differ significantly in their innate resistance to infection with herpes simplex virus type 1 (HSV-1). Three decades ago Lopez reported that C57BL/6 mice could survive a 5,000-fold-higher inoculum of HSV-1 given intraperitoneally than mice of the A or BALB/c strain (Nature 258:152-153, 1975). Susceptible strains of mice died of encephalitis-like symptoms, suggesting that viral spread to the central nervous system was the cause of death. Although Lopez's study documented that C57BL/6 mice were resistant to the development of HSV-1 encephalitis and mortality, the resistance of C57BL/6 mice to other steps of the HSV-1 infection process was not assessed. The results of the present study extend these observations to clarify the difference between resistance to (i) HSV-1 pathogenesis, (ii) HSV-1 replication, (iii) HSV-1 spread, and (iv) the establishment of latent HSV-1 infection. Although C57BL/6 mice are more resistant to HSV-1 pathogenesis than BALB/c mice, the results of the present study establish that HSV-1 enters, replicates, spreads, and establishes latent infections with virtually identical efficiencies in C57BL/6 and BALB/c mice. These observations raise questions about the validity of the inference that differences in natural resistance are relevant in explaining what differentiates humans with recurrent herpetic disease from the vast majority of asymptomatic carriers of HSV-1 and HSV-2.
C57BL/6 mice are more resistant than other inbred strains of mice to the pathogenesis caused by inoculation with murine cytomegalovirus (CMV) (27, 49) , poxviruses (23, 50) , polyomavirus (10) , Trypanosoma congolense (61) , Leishmania major (46) , Angiostrongylus costaricensis (16) , and Brucella abortus (4) . In many of these studies, microbes are injected directly into the peritoneal cavity, and little to no data are presented on the kinetics of microbial replication and spread in the host. Nonetheless, it is often implied that the reduced pathogenesis observed in C57BL/6 mice is a consequence of the inefficient replication of the infectious agent.
A 1975 publication entitled "Genetics of natural resistance to herpesvirus infections in mice" stimulated considerable interest in the hypothesis that animal hosts can differ significantly in their natural susceptibility to infection with herpes simplex virus type 1 (HSV-1) (30) . The intriguing observation was made that C57BL/6 mice survive intraperitoneal (i.p.) inoculation with 10 6 PFU of HSV-1, while the A and BALB/c mouse strains die after i.p. inoculation with 10 6 , 10 5 , or 10 4 PFU of HSV-1 (30) . These observations revealed what appeared to be a previously unrecognized principle of the host-virus interaction: animal hosts can differ tremendously in their susceptibility to HSV-1 pathogenesis. An extensive literature developed out of this observation, and by 1982 it was found that a rapid innate alpha/beta interferon (IFN-␣/␤) response was integral to the increased resistance of C57BL/6 mice to HSV-1 pathogenesis following i.p. challenge with 10 6 PFU of HSV-1 (26, (65) (66) (67) .
Physiologically relevant combinations of IFN-␣/␤ (0.075 nM) and IFN-␥ (1.5 nM) can synergize to inhibit HSV-1 replication by ϳ1,000-fold in vitro (47) . Likewise, treatment of mouse eyes with combinations of recombinant IFN-␤ and IFN-␥ prior to ocular challenge with 10 5 PFU of HSV-1 causes (i) a Ͼ1,000-fold reduction in viral titers in the tear film 24 h after inoculation and (ii) a Ͼ200-fold reduction in the HSV-1 genome load in latently infected trigeminal ganglia (TG) (47) . In light of these observations, we were intrigued by the possibility that the natural resistance of C57BL/6 mice might be due to the combined activities of a rapid IFN-␣ response (65) and a rapid NK cell-mediated response that could rapidly deliver IFN-␥ to sites of viral infection (41) . However, upon reviewing the literature, we were struck by the lack of quantitative methods used to measure the magnitude of natural resistance to HSV-1 replication and spread.
Reduced viral pathogenesis and increased survival are the most prevalent outcomes that have been used to measure the natural resistance of C57BL/6 mice to HSV-1 challenge (2, 30, 38, 40, 55) . Measurements of pathogenesis and survival frequency are qualitative measurements and can be compared only by nonparametric statistics. More importantly, pathogenesis and death are end points that occur 5 to 10 days after HSV-1 inoculation and are the cumulative results of the interaction of the hundreds of variables that dictate the efficiency of viral replication, viral spread, innate immune responses, local inflammatory responses, and the development of an acquired immune response. Therefore, although an extensive literature establishes that C57BL/6 mice are more resistant to HSV-1 pathogenesis than susceptible mouse strains, such measurements do not address the quantitative question, "How much more resistant are C57BL/6 mice to HSV-1 infection than susceptible mouse strains?"
Many studies have addressed facets of this question, but a clear answer has never emerged. Initial comparisons of the 50% lethal doses of HSV-1 in C57BL/6 and BALB/c mice suggested that C57BL/6 mice were Ͼ1,000 times more resistant to HSV-1 challenge than BALB/c mice. The experimental basis for this conclusion was that C57BL/6 mice survived i.p. challenge with 10 6 PFU of HSV-1, whereas 50% of BALB/c mice died after i.p. challenge with just 200 PFU of HSV-1 (30) . The difference in survival is striking. However, the ratio of these 50% lethal doses does not provide a valid basis for concluding that C57BL/6 mice are Ͼ1,000 times more resistant to HSV-1 than BALB/c mice (40, 51, 52) . Kirchner and colleagues established this point when they demonstrated that although most C57BL/6 mice survive i.p. challenge with 10 6 PFU of HSV-1, a 100-fold reduction in the viral inoculum dramatically alters the outcome; C57BL/6 mice do not usually survive i.p. challenge with 10 4 PFU of HSV-1 (65) . This observation was explained by the finding that 10 4 PFU of HSV-1 is sufficient to establish a viral infection in C57BL/6 mice but is not sufficiently immunogenic to trigger a rapid IFN-␣/␤ response (65).
Kirchner's unexpected results brought into sharp focus the importance of the question, "How much more resistant are C57BL/6 mice to HSV-1 infection than susceptible mice?" A clear consensus that resolves this question never emerged in the literature. Some reports indicated that C57BL/6 mouse cells are far less permissive for HSV-1 replication than BALB/c mouse cells (1, 3, 59) . Others concluded that C57BL/6 mouse cells and BALB/c mouse cells are equally permissive for HSV-1 replication (13, 30) . Some suggested that the in vivo replication and spread of HSV-1 are significantly different in C57BL/6 and BALB/c mice (24, 40, 58) . The 1989 report of Simmons and La Vista indicated that HSV-1 replicates to equivalent titers in the skin of C57BL/10 and BALB/c mice but that the spread of viral infection to the spinal ganglia is restricted in C57BL/10 mice (52). More recently, the results of Ellison et al. indicated that there is no difference between the numbers of HSV-1 genomes found in the latently infected TG of C57BL/6 and BALB/c mice (14) .
Although an extensive literature developed out of Lopez's landmark observation (30) , a satisfactory answer has never emerged to one fundamentally important question: "Should the inherited resistance of C57BL/6 mice to pathogenesis be considered (i) a broadly applicable paradigm of inherited resistance to HSV-1 or (ii) an isolated experimental phenomenon?" Like all scientific principles, the answer to this question lies in the predictive value of the paradigm. The predictive value of the paradigm that C57BL/6 mice are inherently resistant to HSV-1 can be objectively assessed by determining how much more resistant C57BL/6 mice are to the processes of HSV-1 infection, replication, spread, and pathogenesis than susceptible mouse strains, such as BALB/c mice. Given the ambiguity in the published literature on these points, we initiated the present study to address the following questions: "Relative to susceptible BALB/c mice, to what extent does the increased resistance of C57BL/6 mice cause (i) a reduction in HSV-1 replication and spread from the site of inoculation, (ii) a reduction in the number of latent HSV-1 genomes established in the TG, (iii) a reduction in the pathogenesis of HSV-1 infections, and (iv) an increase in the innate resistance of C57BL/6 scid mice to HSV-1 infection relative to the innate resistance of BALB/c scid mice?" Experimental results that address these questions are presented herein. Additionally, the effect of natural resistance was compared to two other variables that are potentially relevant in dictating the outcomes of HSV-1 infection, namely, (i) differences in viral virulence and (ii) the extent of damage to the keratinized epithelial barrier at the site of viral inoculation. In light of our results, we conclude that the resistance of C57BL/6 mice to the processes of HSV-1 infection, replication, spread, and pathogenesis is generally overstated in the literature.
MATERIALS AND METHODS
Cells, viruses, and mice. Vero cells (American Type Culture Collection, Manassas, Va.) were propagated in Dulbecco's modified Eagle medium (DMEM) containing 0.15% HCO 3 Ϫ supplemented with 10% fetal bovine serum, penicillin G (100 U/ml), and streptomycin (100 mg/ml) (referred to below as complete DMEM). Wild-type HSV-1 strains KOS (53) and McKrae (25) were propagated in Vero cells. A recombinant strain of KOS that expresses green fluorescent protein (GFP), KOS-GFP, was constructed by the insertion of a CMV immediate-early promoter-GFP gene cassette into the intergenic region between the UL26 and UL27 genes of HSV-1 strain KOS.
Female BALB/c, C57BL/6, BALB/c scid, and C57BL/6 scid mice (5 to 6 weeks old) were obtained from the Jackson Laboratory (Bar Harbor, Maine) and were handled in accordance with the NIH Guide for the Care and Use of Laboratory Animals and the guidelines of the Institutional Animal Care and Use Committee where the work was performed. Prior to HSV-1 infection, mice were anesthetized by i.p. administration of xylazine (6.6 mg/kg of body weight) and ketamine (100 mg/kg). Mice were inoculated by scarifying the cornea with a 26-gauge needle, blotting tear film from the eyes, and placing 10 5 PFU of virus (in a volume of 4 l) on each eye. In experiments in which a light scarification procedure was used, mouse eyes were scratched twice from front to back and twice from top to bottom. When heavy scarification was used, mouse eyes were scratched ϳ15 times from front to back and ϳ15 times from top to bottom.
Analysis of HSV-1 replication in mice. Viral titers in the ocular tear films of mice were determined by swabbing the ocular surfaces of both eyes at the indicated times after inoculation with a cotton-tipped applicator. Following collection of a tear film sample, the tip of the applicator was placed in 0.4 ml of complete DMEM and viral titers were determined by a microtiter plate plaque assay. Fluorescent photographs of the faces of mice infected with HSV-1 strain KOS-GFP were taken at an original magnification of ϫ2 on a Nikon TE300 inverted fluorescent microscope (Nikon Instruments, Lewisville, Tex.). Mice were anesthetized by i.p. administration of xylazine (6.6 mg/kg) and ketamine (100 mg/kg), and a DXC-970MD charge-coupled device camera (Sony Corporation, New York, N.Y.) and Metavue software (Universal Imaging Corporation, Downingtown, Pa.) were used to capture 8 to 10 photographs that covered the right side of each mouse's face. Digital images were stitched together by using Paint Shop Pro (Jasc Software, Eden Prairie, Minn.).
Measurement of HSV-1 DNA load in latently infected mouse TG. DNA was isolated from the combined left and right TG of mice 32 days after inoculation by a phenol-chloroform extraction procedure (60) , and the number of HSV-1 genomes per TG was determined by competitive PCR as described previously (18, 19) . A solution containing 1ϫ Taq buffer, 50 M each deoxynucleoside triphosphate, 0.25 M each VP16 primer (17), 5% glycerol, and 230 fg of a VP16 competitor template per ml (ϳ2,000 competitors per 50-l reaction mixture) was prepared. Forty-two microliters of this master mix was placed in 0.65-ml tubes and overlaid with mineral oil, and 100 ng of TG DNA (3 l) was added to each tube. The tubes were heated to 90°C in a thermal cycler, and 2.5 U of Taq polymerase diluted in 5 l of Taq buffer was added to each sample. PCR samples were incubated for 35 cycles of 94°C for 1 min, 15 s, 59.5°C for 1 min, 15 s, and 72°C for 40 s. VP16 and competitor PCR product yields were measured on a Cyclone PhosphorImager (Perkin-Elmer Life Sciences, Boston, Mass.) as previously described (19, 22) .
Statistics. Analysis of numerical data and statistical analyses were performed with the Microsoft Excel, Modstat (Modern Microcomputers, Mechanicsville, Va.), and CoStat (Cohort Software, Monterey, Calif.) software packages. All data are presented as means Ϯ standard errors of the means (SEM). All viral titers were transformed by adding a value of 1 such that all data could be plotted and analyzed on a logarithmic scale.
RESULTS
KOS replicates efficiently in the eyes of C57BL/6 mice. The replication of HSV-1 strain KOS was compared in the eyes of C57BL/6 and BALB/c mice. Mouse eyes received light scarification (4 scratches per eye) and were inoculated with 10 5 PFU of KOS per eye (n ϭ 8 mice per group). Between days 1 and 5 postinoculation (p.i.), KOS replicated to high and equivalent titers in the eyes of C57BL/6 and BALB/c mice (data not shown). Shedding of KOS ceased in the eyes of both C57BL/6 and BALB/c mice by day 7 p.i. (data not shown). Despite extensive replication and viral shedding at the site of inoculation, 100% of the mice survived infection with KOS, and little to no overt pathogenesis was observed in C57BL/6 and BALB/c mice. Specifically, neither C57BL/6 nor BALB/c mice infected with KOS developed any symptoms of herpes encephalitis (i.e., hyperexcitability, tremors, hindlimb paralysis, etc.), and mice of both strains displayed little to no fur loss in the periocular skin and developed little scarring of the corneal tissues beyond that caused by the process of corneal scarification. In short, the majority of KOS-infected C57BL/6 and BALB/c mice were not readily distinguishable from uninfected mice. Thus, HSV-1 strain KOS replicates efficiently in the eyes of C57BL/6 and BALB/c mice for the first 5 days after inoculation but causes little to no overt pathogenesis in these animals.
KOS-GFP replicates efficiently in the eyes of C57BL/6 mice. The expression of GFP from a recombinant virus, HSV-1 strain KOS-GFP, was compared in the eyes of C57BL/6 and BALB/c mice that received either no, light, or heavy scarification. In mice that received no scarification, only a single focus of GFP expression was visible in 1 of 10 inoculated BALB/c mouse eyes by 24 h p.i. (Fig. 1) . GFP expression was not visible at 24 h p.i. in any eyes of C57BL/6 mice that received no scarification ( Fig. 1) . In C57BL/6 and BALB/c mice that received light or heavy scarification (4 or ϳ30 scratches per eye, respectively), high levels of GFP expression were observed at 24 h p.i. in the corneal lesions produced by scarification but not in the remainder of the eye (Fig. 1 ). GFP expression in mouse eyes was directly proportional to the amount of corneal scarification, but the extent of green fluorescent viral infection did not appreciably differ between C57BL/6 and BALB/c mice (Fig. 1) .
The replication of HSV-1 strain KOS-GFP in the eyes of C57BL/6 and BALB/c mice that received either no, light, or heavy scarification was compared. At 24 h p.i., infectious KOS was detected in the eyes of only 1 of 5 C57BL/6 mice and 1 of 5 BALB/c mice that received no scarification ( Fig. 2A) . By day 4 p.i., however, 3 of 5 C57BL/6 mice and 4 of 5 BALB/c mice that received no scarification shed low titers of infectious KOS-GFP ( Fig. 2A) . In contrast, 100% of C57BL/6 and BALB/c mice that received light or heavy scarification shed high titers of infectious KOS-GFP between days 1 and 5 p.i. (Fig. 2B and  C) . Shedding of KOS-GFP ceased in the eyes of all mice by day 7 p.i. Despite extensive replication and viral shedding at the site of inoculation, 100% of the C57BL/6 and BALB/c mice survived infection with KOS-GFP, and no overt pathogenesis was observed. Thus, HSV-1 strain KOS-GFP replicates with the same efficiency in the eyes of C57BL/6 and BALB/c mice but causes no overt pathogenesis in these animals.
C57BL/6 mice are conditionally resistant to ocular infection with McKrae. The replication of HSV-1 strain McKrae in C57BL/6 and BALB/c mice that received either no, light, or heavy scarification was compared. At 24 h p.i., only 1 of 7 C57BL/6 mice that received no scarification shed detectable levels of infectious McKrae (Fig. 3A) . In contrast, BALB/c FIG. 1. Foci of KOS-GFP infection in the eyes of C57BL/6 and BALB/c mice. C57BL/6 and BALB/c mice that received either 0, 4, or ϳ30 scratches per eye (no, light, or heavy scarification, respectively) were inoculated with 10 5 PFU of HSV-1 strain KOS-GFP/eye (n ϭ 5 mice per group). Twenty-four hours after inoculation, mouse eyes were photographed under illumination with the 360-to 400-nm spectrum of light that excites GFP fluorescence (magnification, ϫ4). Representative photomicrographs from each treatment group are shown except for the BALB/c no-scarification group. Among BALB/c mice that received no scarification, GFP fluorescence was not visible in 9 of 10 mouse eyes 24 h after inoculation with KOS-GFP.
mice that received no scarification shed significantly higher titers of infectious virus at 24 h p.i. (Fig. 3A) (P Ͻ 0.05 by paired t test). Between days 2 and 3 p.i., shedding of McKrae increased to equivalent levels in the eyes of C57BL/6 and BALB/c mice that received no scarification (Fig. 3A) . All C57BL/6 and BALB/c mice that received either light or heavy scarification shed high titers of infectious McKrae between days 1 and 5 p.i. (Fig. 3B and C) . Therefore, only in the absence of corneal scarification was the "resistant" phenotype of C57BL/6 mice made apparent. The survival of C57BL/6 and BALB/c mice infected with HSV-1 strain McKrae was compared over a 28-day observation period. When mice received no scarification, 6 of 7 C57BL/6 mice survived ocular infection with McKrae whereas none of 7 BALB/c mice survived the infection (Fig. 3A) (P ϭ 0.002 by Fisher's exact test). When the efficiency of inoculation was increased by light or heavy scarification, infection with HSV-1 strain McKrae was uniformly lethal in 100% of C57BL/6 and BALB/c mice ( Fig. 3B and C) . Although the final outcome was the same, C57BL/6 mice survived an average 2.6 or 1.4 days longer than their BALB/c counterparts that received light or heavy corneal scarification, respectively. Therefore, C57BL/6 mice consistently survived ocular challenge with HSV-1 strain McKrae for a longer period than BALB/c mice (P Ͻ 0.001 by paired t test). However, only in the absence of corneal scarification was the "resistant" phenotype of C57BL/6 mice sufficient to prevent McKrae infection from progressing to fatal encephalitis.
C57BL/6 scid mice are not inherently more resistant to HSV-1 infection than BALB/c scid mice. An experiment was conducted to test the hypothesis that the resistant C57BL/6 genetic background would prolong the survival of C57BL/6 scid mice relative to that of BALB/c scid mice. The replication of HSV-1 strains KOS, KOS-GFP, and McKrae was compared in C57BL/6, BALB/c, C57BL/6 scid, and BALB/c scid mice that received heavy scarification (n ϭ 8 mice per group). Each of the three viruses replicated to equivalent titers in C57BL/6, BALB/c, C57BL/6 scid, and BALB/c scid mice between days 1 and 5 p.i. (P Ͼ 0.05 by two-way analysis of variance). In agreement with previous results, ocular shedding of KOS, KOS-GFP, and McKrae ceased in immunocompetent C57BL/6 and BALB/c mice by day 7 p.i. In contrast, immunodeficient C57BL/6 scid and BALB/c scid mice shed infectious virus at all times after inoculation (Fig. 4) .
The frequency and duration of survival of immunocompetent C57BL/6 and BALB/c mice were compared. All C57BL/6 and BALB/c mice infected with HSV-1 strain KOS or KOS-GFP survived ocular infection (Table 1) . In contrast, only 1 of 8 C57BL/6 mice and none of 8 BALB/c mice survived ocular infection with HSV-1 strain McKrae. Considering those mice that died, C57BL/6 mice survived for 7.2 Ϯ 0.6 days after inoculation with McKrae and BALB/c mice survived for 5.3 Ϯ 0.2 days (Table 1) . Thus, C57BL/6 mice survived McKrae infection for an average 1.9 days longer than BALB/c mice (P ϭ 0.002 by paired t test).
The innate resistance of C57BL/6 scid and BALB/c scid mice to HSV-1 infection was compared. HSV-1 strain McKrae was rapidly lethal in C57BL/6 scid and BALB/c scid mice, and all McKrae-infected mice died between days 5 and 6 p.i. (Table 1 ; Fig. 4 ). In contrast, C57BL/6 scid and BALB/c scid mice infected with HSV-1 strain KOS or KOS-GFP died between days 12 and 24 p.i. (Table 1; Fig. 4 ). Following inoculation with KOS or KOS-GFP, BALB/c scid mice survived an average of 3 to 4 days longer than C57BL/6 scid mice (Table 1 ; Fig. 4 ) (P ϭ 0.002 by paired t test). Therefore, it is not evident that the C57BL/6 genetic background is functionally superior to the BALB/c genetic background in its capacity to confer innate resistance to HSV-1 infection on scid mice.
KOS-GFP spreads with equivalent efficiency in C57BL/6 scid and BALB/c scid mice. The circuits and synapses of the Mice that received ϳ30 scratches per eye (heavy scarification) were inoculated with 10 5 PFU of the indicated HSV-1 strain/eye (n ϭ 8 mice per group). For each group of mice, mean viral titers recovered from eyes (PFU per eye) are plotted in black as a function of the day after inoculation on which samples were collected. Error bars, SEM. Percent survival of HSV-1-infected C57BL/6 scid and BALB/c scid mice is plotted in red as a function of the day after inoculation. peripheral nervous system are the primary conduit by which HSV spreads in vivo. Thus, the pattern by which ocular HSV-1 infection spreads in mice is a round trip from (i) the eye to (ii) the ophthalmic branch of the TG, to (iii) the brainstem, to multiple nerve centers including (iv) the maxillary and mandibular branches of the TG, to (v) the skin of the nose and the periocular skin (57) .
The round-trip spread of HSV-1 strain KOS-GFP from the eyes to the facial skin of C57BL/6, BALB/c, C57BL/6 scid, and BALB/c scid mice (n ϭ 3 per group) was recorded by photographing the right side of each mouse's face between days 1 and 13 p.i. Between days 1 and 2 p.i., green fluorescent virusinfected cells were visible in the corneas of all KOS-GFPinfected mice but on no other part of the face (data not shown). Between days 4 and 5 p.i., GFP expression was absent from the cornea but began to reappear on the periocular skin and nose as small foci of green florescent viral infection in the facial epithelium. In immunocompetent C57BL/6 and BALB/c mice, limited spread of KOS-GFP infection through the facial epithelium was observed before viral replication was completely suppressed by day 8 p.i. (data not shown). In C57BL/6 scid and BALB/c scid mice, small foci of green fluorescent viral infection appeared in the skin by day 5 p.i. Thereafter, KOS-GFP infection spread centripetally through the epithelium, as is demonstrated by the enlargement of individual sites of green fluorescence between days 5 and 11 p.i. (Fig. 5) . These results indicate that the green fluorescent virus, KOS-GFP, spreads through the peripheral nervous system and facial skin of C57BL/6 scid mice with an efficiency similar to that observed in BALB/c scid mice.
KOS and KOS-GFP establish equivalent numbers of latent viral genomes in TG of C57BL/6 and BALB/c mice. The efficiencies with which HSV-1 establishes latent infections in the TG of C57BL/6 and BALB/c mice were compared. DNA was extracted from the TG of uninfected, latently KOS-infected, and latently KOS-GFP-infected C57BL/6 and BALB/c mice. HSV-1 VP16 and competitor PCR products were coamplified from TG DNA samples isolated from C57BL/6 and BALB/c mice (Fig. 6B) . VP16 PCR products were not amplified from uninfected TG DNA but were consistently amplified from latently HSV-1-infected TG DNA (Fig. 6B) . In parallel reactions, VP16 and competitor PCR products were coamplified from viral DNA standards in order to define the relationship FIG. 5 . Spread of a green fluorescent virus on the skin of C57BL/6 scid and BALB/c scid mice between days 5 and 11 p.i. Composite images of a representative C57BL/6 scid mouse and a representative BALB/c scid mouse were taken 5, 7, 9, and 11 days after inoculation with KOS-GFP. Mice received ϳ30 scratches per eye and were inoculated with 10 5 PFU of KOS-GFP/eye. Composite images were created by stitching together overlapping digital photographs that were taken at the indicated times p.i. on a Nikon TE300 inverted fluorescent microscope (magnification, ϫ2). Arrows point to a single focus of KOS-GFP infection spreading on the face of each mouse over time. Asterisks mark the location of the eye of the C57BL/6 scid mouse. between the VP16 PCR product yield and the number of HSV-1 genomes per PCR (Fig. 6A ) (r 2 ϭ 0.995). The number of HSV-1 genomes per TG in individual C57BL/6 and BALB/c mice was calculated to be the VP16 gene copy number per PCR multiplied by 260 (i.e., ϳ1/260th of the DNA from a single TG was added to each PCR). C57BL/6 and BALB/c mice latently infected with KOS each contained an average of 1.0 ϫ 10 5 viral genomes per TG (Fig. 6C) . Likewise, C57BL/6 and BALB/c mice latently infected with KOS-GFP contained an average of 2.0 ϫ 10 5 and 1.0 ϫ 10 5 viral genomes per TG, respectively (Fig. 6C) . Therefore, HSV-1 strains KOS and KOS-GFP establish latent infections with comparable efficiencies in the TG of C57BL/6 and BALB/c mice.
DISCUSSION
Productive HSV-1 replication in C57BL/6 versus BALB/c mice. It is often stated that C57BL/6 mice are resistant to HSV or that C57BL/6 mice are resistant to HSV infection (7, 9, 12, 21, 40, 48, 66) . These statements range from ambiguous to inaccurate and have led many scientists to the conclusion that C57BL/6 mice are resistant to the processes of HSV-1 infection, replication, and/or viral spread. In the present study, we attempt to clarify this misconception.
There are reports that HSV-1 replicates inefficiently in primary cells derived from C57BL/6 mice, which would suggest that HSV-1 replicates inefficiently in C57BL/6 mice (1, 3). However, these findings contradict the original (1975) conclusions of Lopez, who wrote, "Preliminary evidence indicates that resistance is not a property of structural cells and is probably mediated immunologically. Embryo fibroblast cultures were prepared from A/J, BALB/c and C57BL/6 mice and inoculated with HSV-1. Virus replicated to the same titer in each monolayer, indicating that resistance was not mediated by the inability of HSV-1 to replicate in structural cells of resistant mice" (30) .
The findings of the present study are consistent with the conclusion of Lopez (30) . Throughout the course of this study, viral titers were measured in 336 matched pairs of swabs collected between days 1 and 5 p.i. from the HSV-1-infected eyes of C57BL/6 and BALB/c mice. Regardless of whether the mice were infected with strain KOS, KOS-GFP, or McKrae, equivalent titers of HSV-1 were recovered from matched pairs of C57BL/6 and BALB/c mice (P ϭ 0.35, paired t test; hypothesis H 0 : titer C57BL/6 Ϫ titer BALB/c ϭ 0). Therefore, the results of the present study indicate that host genetic background has no measurable effect on the efficiency with which HSV-1 replicates in the eyes of C57BL/6 and BALB/c mice. Of course, one caveat of the present study is that only the corneal route of infection was studied. Although the study of Simmons and La Vista (52) suggests that HSV-1 also replicates with identical efficiencies in the flank epithelia of C57BL/6 and BALB/c mice, it remains to be determined if C57BL/6 mice and BALB/c mice differ in their resistance to HSV-1 infection when challenged at other anatomic sites such as the footpad or ear pinna.
Establishment of latent HSV-1 infection in C57BL/6 versus BALB/c mice. The results of the present study indicate that equivalent numbers of latent HSV-1 strain KOS genomes are established in the TG of C57BL/6 and BALB/c mice. Likewise, equivalent numbers of latent KOS-GFP genomes are established in the TG of C57BL/6 and BALB/c mice. Our results corroborate the earlier findings of Ellison et al., who observed that equivalent numbers of latent HSV-1 strain KOS genomes were established in the TG of C57BL/6, beige, Swiss Webster, BALB/c, and CBA mice (14) . Despite equivalent total num- bers of HSV-1 genomes per TG, it is possible that large differences could exist in (i) the number of latently HSV-1 infected neurons and (ii) the copy number of viral genomes per neuron in the TG of C57BL/6 and BALB/c mice. The study of Ellison et al. suggests that this is not the case and demonstrates that the number of latently HSV-1 infected neurons per TG does not differ more than twofold between C57BL/6 and BALB/c mice (14) . Although the lack of difference in the latent HSV-1 genome load between the TG of C57BL/6 and BALB/c mice could be due to the insensitivity of the PCR assay, prior results argue against this possibility. A similar PCR procedure has demonstrated that HSV-1 ICP0
Ϫ mutants establish 3-to 15-fold fewer latent viral genomes per TG than wild-type virus in immunocompetent mice (19) . Likewise, a similar PCR assay documented that treatment of mouse eyes with combinations of recombinant IFN-␤ and IFN-␥ prior to ocular challenge with 10 5 PFU of wild-type HSV-1 caused a Ͼ 200-fold reduction in the latent HSV-1 genome load per TG (47) . Therefore, taken together with the findings of Ellison et al. (14) , the results of the present study clearly demonstrate that host genetic background has no significant effect on the efficiency with which HSV-1 establishes a latent infection in the TG of C57BL/6 and BALB/c mice.
The innate resistance of C57BL/6 scid versus BALB/c scid mice. Despite the absence of mature lymphocytes, scid mice possess all of the normal components of the innate immune system (44) . Therefore, like scid mice provide a tool for studying the capacity of the innate immune system to combat the spread of microbial infections without the masking (i.e., dominant) effect of the adaptive immune response which begins to predominate 1 week after inoculation (5, 62) .
The genetic background of the C57BL/6 mouse is believed to contain allelic variants of several genes that confer superior innate resistance to herpesvirus infection relative to that of susceptible mouse strains (8, 32, 35, 39, 41, 45, 49, 51) . In the present study, the predictive value of this hypothesis was tested by comparing the innate resistance of C57BL/6 scid mice and BALB/c scid mice to the processes of HSV-1 replication, spread, and pathogenesis. No significant differences were observed in HSV-1 titers recovered from the eyes of C57BL/6 scid mice and BALB/c scid mice. Likewise, the zosteriform spread of HSV-1 strain KOS-GFP in the facial epithelia of C57BL/6 scid mice and BALB/c scid mice was qualitatively similar at all times after inoculation. Although no differences were noted in the spread of KOS-GFP across the faces of C57BL/6 scid and BALB/c scid mice, it should be noted that differences in spread within the peripheral nervous system may be detectable by more sensitive methods (e.g., the method of Summers et al. [57] or Luker et al. [34] ). Finally, comparison of pathogenesis and death confirmed our expectation that C57BL/6 scid mice would survive infection with HSV-1 strain McKrae for slightly longer (0.5 days) than BALB/c scid mice. However, daily inspection of scid mice infected with one of the less virulent strains, KOS or KOS-GFP, revealed an unexpected pattern. KOS and KOS-GFP infections progressed to fatal encephalitis 3 to 4 days sooner in C57BL/6 scid mice than in BALB/c scid mice (Table 1) . Based on these observations, it is not evident that the allelic differences between the C57BL/6 and BALB/c genetic backgrounds have an appreciable effect on the innate resistance of scid mice to HSV-1 infection, replication, spread, or pathogenesis. This corroborates earlier findings that the resistance of C57BL/6 mice to HSV-1 pathogenesis is absolutely dependent on both (i) the development of a rapid IFN-␣/␤ response (64, 65) and (ii) T-lymphocyte-mediated suppression of HSV-1 replication in infected tissues between days 5 and 7 after inoculation (11, 54) .
Analysis of variables that may affect the pathogenic outcome of HSV-1 infection. Three variables that can potentially impact the pathogenic outcome of HSV-1 infections were compared in the present study: (i) the relative virulence of viral strains, (ii) the degree of epithelial scarification at the time of viral inoculation, and (iii) host genetic background. Without question, the genetic differences between the viral strains McKrae, KOS, and KOS-GFP had a tremendous impact on the pathogenesis that developed in HSV-1-infected mice. In contrast, the genetic differences between C57BL/6 and BALB/c mice had a relatively minor impact on the course of HSV-1 infection, and a difference in the resistance of C57BL/6 and BALB/c mice to HSV-1 pathogenesis was evident only in a subset of the experiments. The relevant conclusions from these comparisons are summarized, as follows.
(i) Relative virulence of HSV-1 strains. In the present study, 100% of C57BL/6 mice (n ϭ 47) and BALB/c mice (n ϭ 47) survived infection with HSV-1 strain KOS or KOS-GFP. Despite the fact that KOS and KOS-GFP infections caused little to no visible pathogenesis in C57BL/6 and BALB/c mice (i.e., little to no loss of fur on the periocular skin), these viruses replicated to high titers in the eyes of mice. In contrast, only 7 of 29 (24%) C57BL/6 mice and none of 29 BALB/c mice survived infection with HSV-1 strain McKrae. Despite the obvious differences in pathogenesis, similar titers of McKrae and KOS were recovered from the eyes of infected mice during the productive phase of infection. An important question that remains to be definitively resolved is which genetic locus or loci in the HSV-1 genome account(s) for the tremendous difference in virulence between virulent and avirulent strains of HSV-1. Given that the increased virulence of HSV-1 strains such as McKrae correlates with an increased resistance to IFN-␣/␤ (56), it would be of interest to determine if the virulence of HSV-1 strain McKrae maps to the interferon resistance locus of HSV-1 that is formed by the adjacent ICP0 and ICP34.5 genes (20, 36, 37) . Although there are some data to support this hypothesis (42) , a rigorous analysis remains to be done.
(ii) Degree of epithelial scarification. An outer layer of keratinized epithelial cells covers the body and serves as a physical barrier to HSV-1 infection. During inoculation, the experimental procedure of scarification breaks this barrier and allows HSV-1 to directly infect the underlying cells that are permissive for HSV-1 replication. In the absence of corneal scarification, KOS-GFP was slow to establish a productive infection in C57BL/6 and BALB/c mice relative to mice that received light or heavy corneal scarification ( Fig. 1 and 2 ). In agreement with previous reports (43), HSV-1 strain McKrae was far more efficient at establishing a productive infection in C57BL/6 and BALB/c mouse eyes that received no scarification (Fig. 3) . In particular, the ϳ1,000-fold-higher titers of McKrae recovered 2 days after inoculation of unscarified corneas demonstrates that HSV-1 strain McKrae is far more ef- Fig. 2A and 3A) . This observation may be relevant to the hypothesis that the increased virulence of HSV- 6 PFU of HSV-1 but that the same HSV-1 inoculum is uniformly lethal in 3-week-old C57BL/6 mice (64). In the present study, we present a similar finding. Most C57BL/6 mice survive ocular inoculation with 10 5 PFU of HSV-1 strain McKrae provided that the viral inoculum is applied to the unscarified cornea. However, when the site of corneal inoculation is scarified, HSV-1 strain McKrae is uniformly fatal in both C57BL/6 and BALB/c mice (Fig. 3) . Thus, the capacity of C57BL/6 mice to resist HSV-1 pathogenesis and death is a conditional phenotype.
Conclusions. Adult C57BL/6 mice mount an unusually rapid IFN-␣/␤ response when infected with HSV-1 (65-67). Plasmacytoid dendritic cells appear to be a major source of this IFN-␣ response in vivo (6) , and their relative absence in juvenile mice appears to account for the age dependence of the resistant phenotype observed in C57BL/6 mice (63). Based on our studies and review of the literature, it appears to us that most of the manifestations of the "resistant " phenotype ascribed to C57BL/6 mice can be explained in terms of a transient IFN-␣/␤-mediated delay in HSV-1 spread from the site of viral inoculation into the peripheral nervous system. For example, we reproducibly observed a 1-to 2-day delay in the onset of McKrae-induced pathogenesis in C57BL/6 mice relative to that in BALB/c mice. Under experimental conditions where either (i) the efficiency of HSV-1 inoculation is low (Fig. 3A) or (ii) the induction of IFN-␣/␤ is rapid (65), a transient delay in HSV-1 replication at the inoculation site may be sufficient to explain the increased survival of C57BL/6 mice relative to that of other inbred strains of mice.
Such experimental details and inferences still do not address a fundamentally important question: "Should the resistance of C57BL/6 mice to pathogenesis be considered a broadly applicable paradigm of inherited resistance to HSV-1?" Based on the fact that HSV-1 enters, replicates, spreads, and establishes latent infections with virtually identical efficiencies in C57BL/6 and BALB/c mice, individuals of the species Mus musculus do not appear to differ fundamentally in their innate resistance to HSV-1 infection. Likewise, although it has been implied that differences in host resistance are relevant in explaining what differentiates humans with recurrent herpetic disease from the vast majority of asymptomatic carriers of HSV-1 and HSV-2 (15, 29, 31, 33) , there is little epidemiological evidence to support this hypothesis.
We conclude that it is quite possible that other explanations may account for this epidemiological observation. For example, the highly variable conditions under which viruses are transmitted in nature (e.g., size of inoculum, duration of sexual contact, abrasion of the epithelium) may be sufficient, in and of themselves, to explain the disparate clinical outcomes of HSV-1 and HSV-2 infection that are observed in human beings. Alternatively, given the tremendous range of virulence observed in HSV-1 laboratory strains, genetic variation in viral strains (e.g., differences in viral resistance to IFN-␣/␤) may be an important factor in the progression of HSV-1 and/or HSV-2 infections to recurrent herpetic disease. Further investigation will be required to determine if, in fact, differences in (i) viral strain and (ii) conditions of viral transmission have a significant impact on the progression of HSV-1 and HSV-2 infections in humans.
